• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对血清型38(美国型71)荚膜多糖的生化与免疫学见解——一种新兴的非疫苗血清型

Biochemical and Immunological Insights into Capsular Polysaccharide of Serotype 38 (American Type 71)An Emerging Nonvaccine Serotype.

作者信息

Reddy M V N Janardhan, Devarakonda Yogeshwar, Burki Rajendar, Syal Kirtimaan

机构信息

Department of Biological Sciences, Birla Institute of Technology and Science, Pilani, Hyderabad Campus, Jawahar Nagar, Kapra Mandal, Medchal District, Telangana 500078, India.

Research & Development, Biological E Limited, Shameerpet, Hyderabad 500078, India.

出版信息

ACS Omega. 2025 Aug 18;10(33):37862-37873. doi: 10.1021/acsomega.5c04889. eCollection 2025 Aug 26.

DOI:10.1021/acsomega.5c04889
PMID:40893316
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12392001/
Abstract

Invasive pneumococcal disease presents a threat to humankind, predominantly affecting children and the elderly. Despite the availability of high-valency pneumococcal polysaccharide vaccine of PPSV23 (PNEUMOVAX 23) and conjugate vaccines such as VAXNEUVANCE and PREVNAR 20, nonvaccine serotypes continue to contribute to higher mortality rates. The characterization of nonvaccine serotypes is becoming increasingly crucial considering an increase in their prevalence. In this study, biochemical characteristics, immunological properties, and critical quality attributes of the capsular polysaccharide isolated from prevalent nonvaccine serotype 38 (American type 71) have been examined. Advanced analytical techniques, including multiangle light scattering (MALS), ion chromatography, and dynamic light scattering in addition to conventional biochemical methods and SLOTBLOT analysis, were employed. We observed that serotype 38 capsular polysaccharide has a molar mass of 768 kDa with a distribution of 1.5 (±4.5%) and a -average radius of gyration ( ) of 90 nm. The polysaccharide composition included galactose, -acetylglucosamine, and galacturonic acid, with a distinct peak indicating the presence of the amino acid serine. The near-zero zeta potential measurements indicated that the polysaccharide is either zwitterionic or uncharged. Serotype 38 polysaccharide exhibited immunological cross-reactivity with serotype 5 and serotype 1 polyclonal sera, likely due to a shared epitope region containing a keto sugar component (Sugp) in their repeating units, along with net charge properties similar to serotype 1. These findings revealed novel characteristics of the serotype 38 polysaccharide, including its amino acid composition and net charge, which may contribute to the development of new therapeutics and effective vaccines.

摘要

侵袭性肺炎球菌疾病对人类构成威胁,主要影响儿童和老年人。尽管有高价肺炎球菌多糖疫苗PPSV23(纽莫法23)以及如沛儿新等结合疫苗,但非疫苗血清型仍导致较高的死亡率。鉴于其流行率的增加,对非疫苗血清型的特征进行鉴定变得越来越关键。在本研究中,对从流行的非疫苗血清型38(美国71型)分离出的荚膜多糖的生化特性、免疫特性和关键质量属性进行了研究。除了传统的生化方法和斑点杂交分析外,还采用了先进的分析技术,包括多角度光散射(MALS)、离子色谱和动态光散射。我们观察到血清型38荚膜多糖的摩尔质量为768 kDa,分布系数为1.5(±4.5%),平均旋转半径( )为90 nm。多糖成分包括半乳糖、N-乙酰葡糖胺和半乳糖醛酸,有一个明显的峰表明存在氨基酸丝氨酸。接近零的zeta电位测量表明该多糖要么是两性离子型要么是不带电的。血清型38多糖与血清型5和血清型1的多克隆血清表现出免疫交叉反应性,这可能是由于它们的重复单元中存在一个包含酮糖成分(Sugp)的共同表位区域,以及与血清型1相似的净电荷特性。这些发现揭示了血清型38多糖的新特性,包括其氨基酸组成和净电荷,这可能有助于开发新的治疗方法和有效的疫苗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5faf/12392001/8ff9366afc3a/ao5c04889_0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5faf/12392001/cd6dada796a7/ao5c04889_0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5faf/12392001/a6d0e3e28541/ao5c04889_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5faf/12392001/fd0a6406b745/ao5c04889_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5faf/12392001/d459ba5512e8/ao5c04889_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5faf/12392001/60d6f49082ac/ao5c04889_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5faf/12392001/f63decfe01ef/ao5c04889_0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5faf/12392001/8ff9366afc3a/ao5c04889_0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5faf/12392001/cd6dada796a7/ao5c04889_0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5faf/12392001/a6d0e3e28541/ao5c04889_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5faf/12392001/fd0a6406b745/ao5c04889_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5faf/12392001/d459ba5512e8/ao5c04889_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5faf/12392001/60d6f49082ac/ao5c04889_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5faf/12392001/f63decfe01ef/ao5c04889_0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5faf/12392001/8ff9366afc3a/ao5c04889_0007.jpg

相似文献

1
Biochemical and Immunological Insights into Capsular Polysaccharide of Serotype 38 (American Type 71)An Emerging Nonvaccine Serotype.对血清型38(美国型71)荚膜多糖的生化与免疫学见解——一种新兴的非疫苗血清型
ACS Omega. 2025 Aug 18;10(33):37862-37873. doi: 10.1021/acsomega.5c04889. eCollection 2025 Aug 26.
2
Immunogenicity and seroefficacy of pneumococcal conjugate vaccines: a systematic review and network meta-analysis.肺炎球菌结合疫苗的免疫原性和血清效力:系统评价和网络荟萃分析。
Health Technol Assess. 2024 Jul;28(34):1-109. doi: 10.3310/YWHA3079.
3
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
4
Immunogenicity and safety of a 14-valent pneumococcal polysaccharide conjugate vaccine (PNEUBEVAX 14™) administered to 6-8 weeks old healthy Indian Infants: A single blind, randomized, active-controlled, Phase-III study.14 价肺炎球菌多糖结合疫苗(PNEUBEVAX 14™)在 6-8 周龄健康印度婴儿中的免疫原性和安全性:一项单盲、随机、阳性对照、III 期研究。
Vaccine. 2024 May 10;42(13):3157-3165. doi: 10.1016/j.vaccine.2024.03.056. Epub 2024 Apr 17.
5
Emergence of a piliated and multidrug-resistant serotype 35B-ST156 clone in Japan.日本出现一株有菌毛且耐多药的35B血清型-ST156克隆株。
Microbiol Spectr. 2025 Sep 2;13(9):e0063225. doi: 10.1128/spectrum.00632-25. Epub 2025 Aug 5.
6
Electrophoresis电泳
7
A decade of 10-valent pneumococcal conjugate vaccine use in Lithuania: trends in invasive pneumococcal serotype dynamics.立陶宛使用10价肺炎球菌结合疫苗的十年:侵袭性肺炎球菌血清型动态变化趋势
Front Public Health. 2025 Aug 1;13:1633396. doi: 10.3389/fpubh.2025.1633396. eCollection 2025.
8
Serotype distribution of Streptococcus pneumoniae causing invasive disease in children in the post-PCV era: A systematic review and meta-analysis.肺炎球菌结合疫苗时代后引起儿童侵袭性疾病的肺炎链球菌血清型分布:一项系统评价和荟萃分析。
PLoS One. 2017 May 9;12(5):e0177113. doi: 10.1371/journal.pone.0177113. eCollection 2017.
9
Quantitative Methods for Evaluating Antibody Responses to Pneumococcal Vaccines: A Scoping Review.评估肺炎球菌疫苗抗体反应的定量方法:一项范围综述
Trop Med Infect Dis. 2025 Aug 21;10(8):236. doi: 10.3390/tropicalmed10080236.
10
CC180 clade dynamics do not universally explain Streptococcus pneumoniae serotype 3 persistence post-vaccine: a global comparative population genomics study.CC180进化枝动态变化并不能普遍解释3型肺炎链球菌疫苗接种后的持续存在情况:一项全球比较群体基因组学研究
EBioMedicine. 2025 Jun 3;117:105781. doi: 10.1016/j.ebiom.2025.105781.

本文引用的文献

1
Streptococcus pneumoniae serotype 38 emerges as one of the dominant serotypes causing invasive pneumococcal disease in Germany and Poland, but not in the Netherlands.肺炎链球菌38型已成为在德国和波兰引起侵袭性肺炎球菌疾病的主要血清型之一,但在荷兰并非如此。
J Infect. 2025 Jul;91(1):106519. doi: 10.1016/j.jinf.2025.106519. Epub 2025 May 26.
2
Structure of the type 38 Streptococcus pneumoniae capsular polysaccharide.38 型肺炎链球菌荚膜多糖的结构。
Carbohydr Res. 2024 Jul;541:109165. doi: 10.1016/j.carres.2024.109165. Epub 2024 May 25.
3
Multi epitope vaccine candidate design against .
针对……的多表位疫苗候选设计
J Biomol Struct Dyn. 2023;41(22):12654-12667. doi: 10.1080/07391102.2023.2167123. Epub 2023 Jan 13.
4
High-Performance Anion-Exchange chromatography with conductivity detection method for simultaneous determination of nitrogen and phosphorus in polysaccharides.高效阴离子交换色谱-电导检测法同时测定多糖中的氮和磷。
J Chromatogr B Analyt Technol Biomed Life Sci. 2022 Sep 1;1207:123367. doi: 10.1016/j.jchromb.2022.123367. Epub 2022 Jul 13.
5
A trial to evaluate the safety and immunogenicity of a 20-valent pneumococcal conjugate vaccine in populations of adults ≥65 years of age with different prior pneumococcal vaccination.一项评估20价肺炎球菌结合疫苗在65岁及以上有不同既往肺炎球菌疫苗接种史的成年人群中的安全性和免疫原性的试验。
Vaccine. 2021 Dec 17;39(51):7494-7502. doi: 10.1016/j.vaccine.2021.10.032. Epub 2021 Nov 25.
6
Multi-Valent Protein Hybrid Pneumococcal Vaccines: A Strategy for the Next Generation of Vaccines.多价蛋白杂交肺炎球菌疫苗:下一代疫苗的一种策略。
Vaccines (Basel). 2021 Mar 2;9(3):209. doi: 10.3390/vaccines9030209.
7
Serotype Distribution of Isolates Causing Invasive and Non-Invasive Infections Using Whole-Genome Sequencing in Ethiopia.在埃塞俄比亚使用全基因组测序对引起侵袭性和非侵袭性感染的分离株进行血清型分布研究
Infect Drug Resist. 2021 Mar 2;14:787-794. doi: 10.2147/IDR.S293578. eCollection 2021.
8
Divergent serotype replacement trends and increasing diversity in pneumococcal disease in high income settings reduce the benefit of expanding vaccine valency.在高收入环境中,肺炎球菌疾病的血清型替代趋势不同,且多样性不断增加,这降低了扩大疫苗效价的获益。
Sci Rep. 2020 Nov 4;10(1):18977. doi: 10.1038/s41598-020-75691-5.
9
Development of Next Generation Vaccines Conferring Broad Protection.具有广泛保护作用的下一代疫苗的研发。
Vaccines (Basel). 2020 Mar 17;8(1):132. doi: 10.3390/vaccines8010132.
10
The shifting epidemiology and serotype distribution of invasive pneumococcal disease in Ontario, Canada, 2007-2017.2007-2017 年加拿大安大略省侵袭性肺炎球菌病的流行趋势和血清型分布变化。
PLoS One. 2019 Dec 13;14(12):e0226353. doi: 10.1371/journal.pone.0226353. eCollection 2019.